Compare · DXCM vs KTWO

DXCM vs KTWO

Side-by-side comparison of DexCom Inc. (DXCM) and K2 Capital Acquisition Corporation (KTWO): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both DXCM and KTWO operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
  • DXCM is the larger of the two at $31.08B, about 153.1x KTWO ($203.0M).
  • DXCM has been more active in the news (13 items in the past 4 weeks vs 3 for KTWO).
  • DXCM has more recent analyst coverage (25 ratings vs 0 for KTWO).
MetricDXCMKTWO
Company
DexCom Inc.
K2 Capital Acquisition Corporation
Price
-
-
Market cap
$31.08B
$203.0M
1M return
-3.21%
-
1Y return
+42.43%
-
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Exchange
NASDAQ
NASDAQ
IPO
2005
2026
News (4w)
13
3
Recent ratings
25
0
DXCM

DexCom Inc.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom G7, a next generation G7 CGM system; and Dexcom Share, a remote monitoring system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop next-generation CGM products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.

Latest DXCM

Latest KTWO